Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study

Dilmen, Ugur; ÖZDEMİR, RAMAZAN; Aksoy, Hatice; Uras, Nurdan; Demirel, Nihal; Kirimi, Ercan; ERDEVE, ÖMER; Ozer, Esra; Bas, Ahmet; Gursoy, Tugba; Zenciroglu, Aysegul; Ovali, Fahri; Oguz, S.

doi:10.3109/14767058.2013.818120

Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study

Atıf İçin Kopyala

Dilmen U., ÖZDEMİR R., Aksoy H. T., Uras N., Demirel N., Kirimi E., ...Daha Fazla

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, cilt.27, sa.4, ss.411-415, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 27 Sayı: 4
Basım Tarihi: 2014
Doi Numarası: 10.3109/14767058.2013.818120
Dergi Adı: JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.411-415
Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

Objective: Surfactant treatment in the early hours of life significantly decreases the rates of death and air leak, and increases survival without bronchopulmonary dysplasia (BPD) in preterm infants. We aimed to compare the impact of early surfactant (ES) administration to late selective (LS) treatment on neonatal outcomes in preterm infants.